PROVIDER PROFILE · NPI 1023428273

Adam Zayac

Hematology-OncologyNew Brunswick, NJI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

Unique beneficiaries

—

Total services

223

Distinct HCPCS

Medicare payment

$27K

Peer benchmark

Total Medicare services vs. 301 Hematology-Oncology providers in NJ — bottom quintile (cohort median 3,501).

PRESCRIBING · PART D · 2024

Total Rx claims

161

Beneficiaries

—

Total drug cost

$253K

Distinct drugs

Brand share

32.3%

Top prescribed drugs

Venetoclax52 claims

Acyclovir26 claims

Azacitidine24 claims

Levofloxacin18 claims

Ondansetron Hcl17 claims

QUALITY · MIPS · 2024

Final MIPS score

88.4

Quality

70.6

Cost

69.4

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.56%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (2)

CCN 310038

Hospital

CCN 310048

Hospital

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history